Atlas Trials

A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People and Patients With Metabolic Dysfunction-associated Steatohepatitis (MASH)

Clinical trial NCT06575400 · RECRUITING

Trial details

NCT number
NCT06575400
Sponsor
Boehringer Ingelheim
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyMetabolic Dysfunction-associated Steatohepatitis
Start date
2024-09-12
Primary completion
2028-02-02
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.